Fundz

Kashiv BioSciences Secures INR 648 Crore Financing from Union Bank of India to Expand Manufacturing Facilities in Gujarat.

RECENTLY ACQUIREDDec 23, 2025

Amount Raised

₹6.48 Billion

Round Type

Debt Financing

BridgewaterManufacturingBiotechnologyHealth Care

Investors

Union Bank Of India

Description

Kashiv BioSciences announced that it has secured financing of INR 648 crore from the Union Bank of India. The funds will be used to expand its manufacturing facility in Pipan, Gujarat. This new facility will enhance Kashiv’s biomanufacturing capacity and create employment opportunities. The financing is a key milestone in strengthening India’s role in the global biopharmaceutical market.

Quick answer

Kashiv BioSciences raised ₹6.48 Billion in a Debt Financing round, dated December 23, 2025. Investors: Union Bank Of India. Kashiv BioSciences is based in Bridgewater, New Jersey, United States.

How much did Kashiv BioSciences raise?
Kashiv BioSciences raised ₹6.48 Billion in a Debt Financing round on December 23, 2025.
Who invested in Kashiv BioSciences?
Union Bank Of India is named as investors in this round.
What does Kashiv BioSciences do?
Kashiv BioSciences, LLC is a company that focuses on developing and manufacturing high-quality, affordable biosimilars to improve patients’ lives worldwide.
Where is Kashiv BioSciences based and how big is it?
Kashiv BioSciences is based in Bridgewater, New Jersey, United States. Fundz records about 487 employees.
Who are the decision-makers at Kashiv BioSciences?
Fundz holds 3 contacts at Kashiv BioSciences, including the Human Resources Business Partner. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Kashiv BioSciences that raised within 45 days of this round, from Fundz verified event records.

  • NuVision Biotherapies raised $6.6M on February 5, 2026.
  • Nami Surgical raised $2.6M (Seed) on January 28, 2026.
  • Stellular Bio raised an undisclosed amount (Funding Round) on January 28, 2026.
  • IM Cannabis Corp raised $2.2M (Debt Financing) on January 26, 2026.
  • Novabay raised $134M on January 16, 2026.
  • Conavi Medical raised $700K (Seed) on January 13, 2026.

Who to call at Kashiv BioSciences, and when

A new round usually means Kashiv BioSciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kashiv BioSciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kashiv BioSciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kashiv BioSciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kashiv BioSciences

Location

Bridgewater, New Jersey, United States

About

Kashiv BioSciences, LLC is a company that focuses on developing and manufacturing high-quality, affordable biosimilars to improve patients’ lives worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kashiv BioSciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsShailesh L., Human Resources Business Partner hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Kashiv BioSciences's next move

See what Strategic adds

Kashiv BioSciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.